BD IV Catheter #381433
Becton Dickinson Vialon, a unique proprietary biomaterial, has been proven to enhance clinical and economic outcomes. Increases the ease of penetration. Reduces the risks of infiltration. Exhibits greater kink resistance. Reduces the risks of phlebitis up to 50%. Reduces IV restarts due to reduced complications. Increases indwelling time. Reduces the total IV therapy costs to use due to longer indwelling times.